申请人:Genentech, Inc.
公开号:US20200115388A1
公开(公告)日:2020-04-16
Compounds of Formula 0, and stereoisomers and pharmaceutically acceptable salts thereof, as well as methods of use as Interleukin-1 Receptor Associated Kinase (IRAK4) inhibitors are described herein.